The Association between Spouse-Reported Type a Behaviour Pattern and Coronary Heart Disease

1994 ◽  
Vol 28 (2) ◽  
pp. 298-301 ◽  
Author(s):  
Michelle Atchison ◽  
John Condon

This paper describes further validation of the Spouse-Report Type A Behaviour Pattern Questionnaire. In a case controlled study of 61 cardiac patients versus 61 community controls, the questionnaire was found to discriminate statistically between a group of patients with proven coronary heart disease and a group of matched healthy controls on the anger/hostility subscale and total Type A score. No relationship between Type A score and coronary heart disease severity was found. Possible explanations for these findings are examined.

1985 ◽  
Vol 15 (3) ◽  
pp. 581-588 ◽  
Author(s):  
Christopher C. Tennant ◽  
Pauline M. Langeluddecke

SynopsisThe Type A behaviour pattern and other measures of psychological traits and symptom states were assessed in 92 subjects (predominantly male) presenting for coronary angiography. These measures were correlated with three angiographic indices of coronary heart disease (CHD) severity and two clinical indices (angina and the duration of CHD). The only psychological measures associated with atherosclerosis (assessed by angiography) were indices of personality: Type A (the Jenkins Activity Survey), trait tension, trait anxiety and suppression of anger. It was concluded that these traits may have some role in the pathogenesis of coronary atherosclerosis. None of the measures of psychological symptoms showed a significant association with angiography indices. However, depressive symptoms and expressed hostility were associated with the severity of angina and duration of heart disease. It was concluded that these affects are the consequences of the physical disability of CHD.


1996 ◽  
Vol 26 (1) ◽  
pp. 29-34 ◽  
Author(s):  
Timothy A. Barry ◽  
Douglas R. Wassenaar

This study investigated the relationship between coronary heart disease and a number of established coronary risk factors among Indian males. Included were factors such as Type A behaviour pattern (sometimes referred to as the coronary-prone behaviour pattern). The study investigated whether the following coronary risk factors were able to distinguish those with myocardial infarction from controls: Type A behaviour pattern, stress levels, anger levels, diabetes, previous coronary heart disease, hypertension, obesity, family history of coronary heart disease, physical exercise, cigarette smoking and alcohol consumption. Statistical analysis indicated that none of the risk factors, except Type A behaviour pattern, were able to significantly distinguish the myocardial infarction group from controls.


2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Yuzhen Li ◽  
Tianqi Tao ◽  
Dandan Song ◽  
Tao He ◽  
Xiuhua Liu

Despite advances in the drug treatment strategy for stable coronary heart disease (CHD), the mortality of CHD continues to rise. New or adjuvant treatments would be desirable for CHD. Xuefu Zhuyu granules are derived from the formula of traditional Chinese medicine. To determine whether Xuefu Zhuyu granules might have adjuvant effects on stable CHD, we conducted a controlled clinical trial. Patients with stable CHD were enrolled and randomly assigned to receive Xuefu Zhuyu granules or placebo for 12 weeks in addition to their standard medications for the treatment of CHD. The primary endpoints comprise the Canadian Cardiovascular Society Angina Grading Scale (CCS class), echocardiographic measures, Seattle Angina Questionnaire (SAQ), and coronary artery CT. The secondary endpoints included the parameters of nailfold capillary measurement and cutaneous blood perfusion (CBP). After 12 weeks of follow-up, there was a great improvement of the Canadian Cardiovascular Society Angina Grading Scale (CCS class) in the Xuefu Zhuyu group compared with the placebo group ( p < 0.01 ). Also, a decrease was found in the percentage of patients with CCS class II in the Xuefu Zhuyu group between follow-up at 12 weeks and baseline ( p < 0.01 ). We observed a significant increase in SAQ scores of physical limitation ( p < 0.01 ) and treatment satisfaction ( p < 0.05 ) in patients receiving Xuefu Zhuyu treatment at 12 weeks in comparison with those at baseline, but not in placebo treatment ( p > 0.05 ). Amelioration in coronary artery stenosis in the Xuefu Zhuyu group was noted ( p < 0.05 ). Xuefu Zhuyu granule treatment led to great improvements in cutaneous blood perfusion at follow-up of 12 weeks compared with placebo ( p < 0.05 ). These findings suggest that on a background of standard medications, Xuefu Zhuyu granules have the ability to further improve the prognosis of patients with stable CHD.


Sign in / Sign up

Export Citation Format

Share Document